These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 11265923
21. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J. Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335 [Abstract] [Full Text] [Related]
22. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T, MTA Cooperative Group. J Atten Disord; 2008 Jul; 12(1):15-43. PubMed ID: 18573924 [Abstract] [Full Text] [Related]
23. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, Simpson S, Shapiro C, Bukstein O, Baron-Myak C, McBurnett K. J Abnorm Child Psychol; 2000 Dec; 28(6):507-25. PubMed ID: 11104314 [Abstract] [Full Text] [Related]
28. Methylphenidate Has Superior Efficacy Over Parent-Child Interaction Therapy for Preschool Children with Disruptive Behaviors. van der Veen-Mulders L, van den Hoofdakker BJ, Nauta MH, Emmelkamp P, Hoekstra PJ. J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):66-73. PubMed ID: 29131677 [Abstract] [Full Text] [Related]
29. Psychosocial treatment issues in the MTA: a reply to Greene and Ablon. Hoza B. J Clin Child Psychol; 2001 Mar; 30(1):126-30. PubMed ID: 11294071 [Abstract] [Full Text] [Related]
36. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. Kolko DJ, Bukstein OG, Barron J. J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190 [Abstract] [Full Text] [Related]
37. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, COMACS Study Group. Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578 [Abstract] [Full Text] [Related]
38. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR, MTA Cooperative Group. J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):484-500. PubMed ID: 19318991 [Abstract] [Full Text] [Related]